Colgate-Palmolive Company (NYSE:CL) has been experiencing both upward and downward shifts in its stock holdings. Commerzbank Aktiengesellschaft FI, AustralianSuper Pty Ltd, Wealthfront Advisers LLC, Edgestream Partners L.P. and others have augmented their stakes, while Bryn Mawr Capital Management LLC, Savoir Faire Capital Management L.P., Massachusetts Financial Services Co. MA, and many others have decreased their positions. The company's share experienced a nine-day losing streak, leading to a negative 6.4% return. Institutional owners making up 86% of all shareholders, showing confidence in the company. However, the price target was cut to $106.00 by analysts at UBS Group, despite another group raising it to $87.00.
Colgate-Palmolive shareholders experienced a 44% return over the past five years, and the company is known for being a reliable source of long-term dividend income. Despite ongoing global uncertainty, the company's earnings in Q1 remained stable. Although the stock faces challenges due to reduced consumer spending, it's considered among the best FMCG stocks to buy according to hedge funds.
Colgate-Palmolive Company CL News Analytics from Fri, 31 Jan 2025 08:00:00 GMT to Sat, 19 Jul 2025 19:51:08 GMT -
Rating -1
- Innovation 2
- Information 5
- Rumor -2
